NASDAQ: HOWL
Werewolf Therapeutics Inc Stock Ownership - Who owns Werewolf Therapeutics?

Insider buying vs selling

Have Werewolf Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ra Capital Management LPDirector2025-05-14162,539$0.98
$159.29kBuy
Ra Capital Management LPDirector2025-05-1352,974$0.98
$51.91kBuy
Ra Capital Management LPDirector2025-05-12320,913$0.86
$275.99kBuy
Ansbert Gadicke10% Owner2025-03-274,386$1.05
$4.61kSell
Luke EvninDirector2025-03-2728,113$0.09
$2.53kBuy
Mpm Bioventures 2014 LP10% Owner2025-03-271,963$1.05
$2.06kSell
Mpm Bioventures 2014 LP10% Owner2025-03-2722,758$0.09
$2.05kBuy
Luke EvninDirector2025-03-272,425$1.05
$2.55kSell
Ansbert Gadicke10% Owner2025-03-2750,873$0.09
$4.58kBuy

1 of 1

HOWL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HOWL insiders and whales buy or sell their stock.

HOWL Shareholders

What type of owners hold Werewolf Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke14.97%6,718,670$8.00MInsider
Ra Capital Management LP13.69%6,144,881$7.31MInstitution
Mpm Asset Management LLC9.60%4,309,860$5.13MInstitution
Luke Evnin9.60%4,309,860$5.13MInsider
Mpm Bioventures 2014 LP7.15%3,208,793$3.82MInsider
James E. Flynn5.69%2,552,787$3.04MInsider
Pfm Health Sciences LP5.59%2,506,520$2.98MInstitution
Mpm Bioimpact LLC5.37%2,408,810$2.87MInstitution
Bank Of America Corp4.69%2,103,142$2.50MInstitution
Taiho Ventures LLC4.61%2,068,909$2.46MInsider

1 of 3

HOWL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HOWL47.80%52.20%Net BuyingNet Buying
SER0.84%99.16%Net Buying
KRON31.38%34.90%Net SellingNet Selling
DTIL12.12%87.88%Net SellingNet Buying
IFRX25.86%0.00%

Werewolf Therapeutics Stock Ownership FAQ

Who owns Werewolf Therapeutics?

Werewolf Therapeutics (NASDAQ: HOWL) is owned by 61.16% institutional shareholders, 66.79% Werewolf Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Werewolf Therapeutics shareholder, owning 6.72M shares representing 14.97% of the company. Ansbert Gadicke's Werewolf Therapeutics shares are currently valued at $8.00M.

If you're new to stock investing, here's how to buy Werewolf Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.